Oncothyreon Inc. — Form D
Oncothyreon Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-15. The offering totals $20.2M, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-07-15
- Form: D
- Accession: 0001412067-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $20.2M
- Amount sold: $200K
- Remaining: $20.0M
- Investors: 1
- Date of first sale: 2010-07-06
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-144978
Issuer
- Name: Oncothyreon Inc.
- CIK: 0001412067
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 2601 FOURTH AVENUE, SEATTLE, WA, 98121
- Phone: (206) 801-2100
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Gary Vickery Christianson | Executive Officer | Seattle, WA |
| Shashi K Karan | Executive Officer | Seattle, WA |
| RICHARD L JACKSON | Director | OAK BROOK, IL |
| Christopher S Henney | Director | Berkeley Heights, NJ |
| Ted W Love | Director | Cranbury, NJ |
| Scott L Peterson | Executive Officer | Seattle, WA |
| Gary L Christianson | Executive Officer | Seattle, WA |
| Diana L Hausman | Executive Officer | Seattle, WA |
| Robert L Kirkman | Director | Seattle, WA |
| Robert L Kirkman | Executive Officer | Seattle, WA |
| Julia L Eastland | Executive Officer | Seattle, WA |
| Daniel W Spiegelman | Director | Seattle, WA |
| W. Vickery Stoughton | Director | Seattle, WA |
| Jay L Venkatesan | Executive Officer | Seattle, WA |
| Christopher L Henney | Director | Seattle, WA |
| Daniel K Spiegelman | Director | San Francisco, CA |
| DOUGLAS VICKERY WILLIAMS | Director | SEATTLE, WA |
| JULIA MARIE EASTLAND | Executive Officer | SEATTLE, WA |
Other filings by this issuer (3)
More